» Authors » Carlo M Croce

Carlo M Croce

Explore the profile of Carlo M Croce including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 582
Citations 70336
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tigu A, Munteanu R, Moldovan C, Rares D, Kegyes D, Tomai R, et al.
Cell Death Discov . 2024 Nov; 10(1):471. PMID: 39551787
Receptor tyrosine kinases (RTKs) are key cell surface receptors involved in cell communication and signal transduction, with great importance in cell growth, differentiation, survival, and metabolism. Dysregulation of RTKs, such...
2.
Tomuleasa C, Tigu A, Munteanu R, Moldovan C, Kegyes D, Onaciu A, et al.
Signal Transduct Target Ther . 2024 Aug; 9(1):201. PMID: 39138146
Receptor tyrosine kinases (RTKs), a category of transmembrane receptors, have gained significant clinical attention in oncology due to their central role in cancer pathogenesis. Genetic alterations, including mutations, amplifications, and...
3.
Tili E, Otsu H, Commisso T, Palamarchuk A, Balatti V, Michaille J, et al.
Proc Natl Acad Sci U S A . 2024 Jul; 121(29):e2408649121. PMID: 38980909
Elevated levels of in solid and liquid malignancies correlate with aggressiveness of the disease. In this manuscript, we show that targets transcripts encoding IcosL, the ligand for Inducible T-cell costimulator...
4.
Mills J, Tessari A, Anastas V, Kumar D, Rad N, Lamba S, et al.
bioRxiv . 2024 Jul; PMID: 38948867
Nucleoli are large nuclear sub-compartments where vital processes, such as ribosome assembly, take place. Technical obstacles still limit our understanding of the biological functions of nucleolar proteins in cell homeostasis...
5.
Kim S, Lee K, Yoo Y, Park S, Lee J, Jeon S, et al.
Anim Cells Syst (Seoul) . 2024 May; 28(1):184-197. PMID: 38693921
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has chemotherapeutic potential as a regulator of an extrinsic apoptotic ligand, but its effect as a drug is limited by innate and acquired resistance....
6.
Tomasello L, Holub S, Nigita G, Distefano R, Croce C
Signal Transduct Target Ther . 2024 Apr; 9(1):90. PMID: 38616203
No abstract available.
7.
Rampioni Vinciguerra G, Capece M, Reggiani Bonetti L, Nigita G, Calore F, Rentsch S, et al.
Signal Transduct Target Ther . 2024 Feb; 9(1):31. PMID: 38342897
Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease, characterized by an intense desmoplastic reaction that compresses blood vessels and limits nutrient supplies. PDAC aggressiveness largely relies on its extraordinary capability...
8.
La Ferlita A, Alaimo S, Nigita G, Distefano R, Beane J, Tsichlis P, et al.
iScience . 2024 Feb; 27(2):108810. PMID: 38303722
tRNA-derived ncRNAs are a heterogeneous class of non-coding RNAs recently proposed to be active regulators of gene expression and be involved in many diseases, including cancer. Consequently, several online resources...
9.
Cataldo A, Cheung D, Hagan J, Fassan M, Sandhu-Deol S, Croce C, et al.
Noncoding RNA . 2024 Jan; 10(1). PMID: 38250804
MiRNAs play crucial roles in a broad spectrum of biological processes, both physiological and pathological. Different reports implicate miR-205 in the control of breast stem cell properties. Differential miR-205 expression...
10.
Rampioni Vinciguerra G, Capece M, Scafetta G, Rentsch S, Vecchione A, Lovat F, et al.
Cell Death Differ . 2023 Dec; 31(2):136-149. PMID: 38104183
Fos-related antigen-2 (Fra-2) is the most recently discovered member of the Fos family and, by dimerizing with Jun proteins, forms the activator protein 1 (AP-1) transcription factor. By inducing or...